The efficacy and safety of a single dose of Clindesse™ vaginal cream versus a seven-dose regimen of Cleocin® vaginal cream in patients with bacterial vaginosis

15Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Objective. To determine whether a single dose of Clindesse™ vaginal cream is comparable in efficacy and safety to Cleocin® vaginal cream administered once daily for 7 days in the treatment of bacterial vaginosis. Study design. This multicenter, randomized, single-blind, parallel-group study enrolled 540 patients with BV infections. Treatment consisted of either a single intravaginal dose of Clindesse™ or 7 daily doses of Cleocin®. Efficacy and safety were assessed 21-30 days after the start of treatment. The efficacy endpoints were Investigator Cure, Clinical Cure (a composite of all 4 Amsel's criteria and Investigator Cure), Nugent Cure (Nugent score < 4), and Therapeutic Cure (a composite of Clinical Cure and Nugent Cure). Resolution of individual Amsel's criteria was also evaluated. Treatment-emergent adverse events were monitored throughout the study. Results. There were no significant differences in cure rates between the Clindesse™ and Cleocin® treatment groups in Investigator Cure (P=0.702), Clinical Cure (P=0.945), Nugent Cure (P=0.788), or Therapeutic Cure (P=0.572). Results were also similar for 3 of 4 and 2 of 4 Amsel's criteria and for each individual Amsel's criterion (all P-values > 0.200). Ninety-five percent confidence intervals for each endpoint were consistent with equivalence between the 2 products. There was no significant difference between the treatment groups in the incidence of treatment-emergent adverse events (P=0.386). Conclusions. A single dose of Clindesse™ vaginal cream is equivalent in safety and efficacy to a 7-dose regimen of Cleocin® vaginal cream in the treatment of bacterial vaginosis. This represents a significant advance in the treatment of bacterial vaginosis. © 2005 Taylor & Francis.

Cite

CITATION STYLE

APA

Faro, S., & Skokos, C. K. (2005). The efficacy and safety of a single dose of ClindesseTM vaginal cream versus a seven-dose regimen of Cleocin® vaginal cream in patients with bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology, 13(3), 155–160. https://doi.org/10.1080/10647440500148321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free